Pharmaron Beijing Co., Ltd.

Pharmaron Beijing Co., Ltd. is a leading fully-integrated pharmaceutical research and development services platform, listed on the ChiNext board of the Shenzhen Stock Exchange since 2019. The company operates globally, focusing on accelerating drug innovation for its customers by providing comprehensive drug research, development, and manufacturing services throughout the entire research and development cycle. With 21 R&D centers and manufacturing facilities located in China, the U.K., and the U.S., Pharmaron is committed to enhancing the efficiency and flexibility of pharmaceutical R&D and manufacturing needs. The company's main business lines include services for small molecule drugs, biologics, and cell and gene therapy (CGT) products. Pharmaron's end-to-end business model allows it to deepen customer collaboration and establish core technical expertise, which supports innovative R&D programs. The company is dedicated to expanding its global service platform and utilizing innovative technologies to meet evolving R&D needs, while also fostering a reputable and loyal customer base that contributes to its sustainable growth.

The Company provides customers with fully-integrated services covering drug research, development and manufacturing services for innovative pharmaceutical products throughout the research and development cycle. With this end-to-end and fully-integrated business model, we gain significant competitive advantages in deepening customer collaboration, establishing core technical expertise and professional team building which enable us to better support our customers’ innovative R&D programs. 1. Leading fully-integrated pharmaceutical R&D services platform with strong capabilities and comprehensive service offerings across the globe. 2. Global operations, profound experience in pharmaceutical R&D and state-of-the art technologies to provide customized solutions. 3. Committed to utilizing innovative technologies to meet evolving R&D needs and increase efficiency. 4. Dedicated, stable and visionary management teams, experienced talent pools with progressive corporate culture. 5. Reputable, loyal and expanding customer base that contributes to our sustainable growth and business collaboration.